Skip to main content
Global Edition
Monday, January 25, 2021


Vaccine against COVID-19


CoronaVac is a COVID-19 vaccine candidate developed by the Chinese biopharmaceutical company Sinovac. Beginning in mid-2020, the vaccine candidate was undergoing Phase III clinical research; it is in Phase III trials in Brazil, Chile, Indonesia and Turkey. CoronaVac uses a similar, more traditional technology as in BBIBP-CorV and BBV152, other inactivated-virus vaccines for COVID-19 in Phase III trials.

0 shares 1 views

News coverage

You might like